Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 2009. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of insider share transactions and contains no financial performance data.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The only change disclosed is a personal transaction by a director involving the transfer of company shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a compliance notification under Disclosure Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Type: Gift of shares by a director to family members.
- Director Involved: Mr. Andrew P. Witty.
- Details: Transfer of 500 Ordinary shares to each of his two children (total 1,000 shares).
- Transaction Date: December 18, 2009.
- Notification Date: The company was advised on December 18, 2009; the report was signed on December 21, 2009.